Organisation paid for research Program year 2025 Source: CMS Open Payments

Be Well Clinical Studies Austin

Neither a doctor nor a teaching hospital

Research payments

$1,683,146

6 payments

Through program year 2025, Be Well Clinical Studies Austin is reported as receiving $1,683,146 in research payments, across 6 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$1,325,897	3
2024	Research	$351,937	2
2023	Research	$5,312	1

Breakdown

Who paid Research payments · program years 2023–2025

Vertex Pharmaceuticals Incorporated $1,683,146 6 payments

Studies the money was for Research payments · program years 2023–2025

A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-design Study of the Efficacy and Safety of Suzetrigine in Subjects With Painful Diabetic Peripheral Neuropathy $1,006,653 2 payments
A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel-design Study of the Efficacy and Safety of VX-548 in Subjects With Painful Lumbosacral Radiculopathy $344,943 3 payments
A Phase 3, Open-label Study Evaluating the Long-term Safety and Effectiveness of Suzetrigine in Subjects With Pain Associated With Diabetic Peripheral Neuropathy $331,550 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.